Study for efficacy of measuring plasma progesterone during adrenal venous sampling in patients with primary aldosteronism

Study for efficacy of measuring plasma progesterone during adrenal venous sampling in patients with primary aldosteronism - Efficacy of measuring plasma progesterone during AVS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034378

Enrollment

Registered

2018-10-04

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients underwent adrenal venous sampling in Nagasaki University Hospital

Exclusion criteria

Exclusion criteria: Patients administered with steroid.

Design outcomes

Primary

Measure	Time frame
To study the efficacy for diagnosis of localization of aldosterone producing tumor by using ratio of aldosterone to progesterone compared with ratio of aldosterone to cortisol.	—

Secondary

Measure	Time frame
To study the efficacy for diagnosis of localization of aldosterone producing tumor by using ratio of aldosterone to progesterone even in patients complicated with Cushing's syndrome.	—

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Endocrinology and Metabolism

holy197741@me.com0958197200

Outcome results